Microbix Appoints New President and Chief Executive Officer
Microbix Biosystems Inc. announced that its Board of Directors has appointed Vaughn Embro-Pantalony as President and Chief Executive Officer.
Mr. Embro-Pantalony succeeds William J. Gastle who becomes Executive Chairman. Mr. Embro-Pantalony has been a member of the Microbix Board of Directors and Audit Committee since 2007. He has held senior executive roles in large biopharmaceutical and agriculture companies, including CFO at Novopharm Ltd and Bayer Healthcare, CIO at Bayer Inc and General Manager of Terra Canada's Nitrogen Division. Most recently he was CEO of StratPath Management Inc., consulting with life science companies on strategy and governance issues. Mr. Embro-Pantalony has a BA in Economics, an MBA, is a Fellow of the Society of Management Accountants of Canada and holds the designations Chartered Director and Audit Committee Certified.
The Company also announced that Phil Casselli, previously President of Microbix, is appointed to Senior Vice-President, Sales and Business Development. In this re-focused role, Mr. Casselli will be responsible for the top-line growth of Microbix and for the LumiSort animal reproduction venture.
Other news from the department people
